Nanostructured surfaces

US10493793B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10493793-B2
Application numberUS-201113639928-A
CountryUS
Kind codeB2
Filing dateApr 11, 2011
Priority dateApr 9, 2010
Publication dateDec 3, 2019
Grant dateDec 3, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to methods for inhibiting growth of bacteria and to nanometer scale surfaces having antibacterial properties.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of reducing growth of bacteria on a surface of a polyvinyl chloride substrate comprising: altering the surface of the polyvinyl chloride substrate to produce a nanometer scale surface geometry by: contacting the surface of the polyvinyl chloride substrate with a solution of a nano-roughing agent to produce a nanometer scale surface geometry on the surface of the substrate, and contacting the surface with bacteria, wherein growth of the bacteria on the altered polyvinyl chloride surface is inhibited by about 30% to about 50%, as measured by contacting the altered polyvinyl chloride surface with Staphylococcus aureus bacteria for 4 to 72 hours as compared to contacting the untreated polyvinyl chloride surface with Staphylococcus aureus bacteria for 4 to 72 hours. 2. The method of claim 1 wherein the nano-roughing agent is one or more of an acid, a base, a bacterial lipase, an alcohol, a peroxide, isoamyl acetate, dichloromethane, isoamyl acetate with zinc, dichloromethane with zinc, acetic acid, sulfuric acid, nitric acid, perchloric acid, phosphoric acid, hydrochloric acid, chloroform, acetone, ethanol, ammonia, sodium hydroxide, potassium hydroxide, ammonium hydroxide, ammonium fluoride, hydrofluoric acid, triflic acid, hydrogen peroxide, dichloroethylene, or xylene. 3. The method of claim 1 wherein the nano-roughing agent is one or more of phospholipases, sphingomyelinases, hepatic lipase, endothelial lipase, lipoprotein lipase, bile salt dependent lipase, pancreatic lipase, lysosomal lipase, hormone-sensitive lipase, gastric lipase, pancreatic lipase related protein 2, pancreatic lipase related protein 1, lingual lipase, and bacterial lipase produced from one or more of Rhisopus arrhisus, Candida cilindracea, Candida rugosa, Thermus thermophilus, Candida Antarctica, Aspergillus niger, Aspergillus oryzae, Aspergillus sp, Burkholderia sp, Candida utilis, Chromobacterium viscosum, Mucor javanicus, Penicillium roqueforti , or Pseudomonas cepacia. 4. The method of claim 1 wherein the surface of the substrate is contacted with a solution of Rhisopus arrhisus or Candida cilindracea. 5. The method of claim 1 wherein the substrate further includes a metal, wherein the metal is one or more of titanium, aluminum, platinum, niobium, tantalum, tin, nickel, cobalt, chromium, molybdenum, stainless steel, nitinol, SiN, CoCrMo, or mixtures or alloys thereof. 6. The method of claim 1 wherein the substrate further includes a ceramic, wherein the ceramic is one or more of alumina, hydroxyapatite, silica, calcium phosphates, or bone cements, or composites thereof. 7. The method of claim 1 wherein the substrate is an endotracheal tube. 8. The method of claim 1 wherein the bacteria is one or more of Staphylococcus aureus, Staphylococcus epidermis, Pseudomonas aeruginosa , MRSA, E. coli, candida (yeast), Streptococcus pneumoniae, Neisseria meningitides, Haemophilus influenzae, Streptococcus agalactiae, Listeria monocytogenes, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila, Mycobacterium , tuberculosis, Streptococcus pyogenes, Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema pallidum, Ureaplasma urealyticum, Haemophilus ducreyi, Helicobacter pylori, Campylobacter jejuni, Salmonella, Shigella, Clostridium , Enterobacteriaceae, or Staphylococcus saprophyticus. 9. The method of claim 1 , wherein the surface of the substrate includes a metal, wherein the metal is one or more of platinum, tin, molybdenum, stainless steel, SiN, or mixtures or alloys thereof. 10. The method of claim 1 , wherein the surface of the substrate includes a ceramic, wherein the ceramic is one or more of alumina, silica, calcium phosphates, or bone cements, or composites thereof.

Assignees

Inventors

Classifications

  • Tracheal tubes (catheters in general A61M25/00) · CPC title

  • Continuous and nonuniform or irregular surface on layer or component [e.g., roofing, etc.] · CPC title

  • Aqueous compositions · CPC title

  • B44C1/227Primary

    by etching · CPC title

  • Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10493793B2 cover?
The present invention is directed to methods for inhibiting growth of bacteria and to nanometer scale surfaces having antibacterial properties.
Who is the assignee on this patent?
Webster Thomas J, Univ Brown
What technology area does this patent fall under?
Primary CPC classification B44C1/227. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).